Opiates, Urine, Quantitative
Ordering Recommendation
Preferred test to follow-up presumptive results. For general screening, Opiates, Urine Screen with Reflex to Quantitation (2005093) is preferred.
New York DOH Approval Status
Specimen Required
Random urine.
Transfer 0.5 mL with no additives or preservatives urine to an ARUP Standard Transport Tube. (Min: 0.3 mL)
Room temperature.
Specimens exposed to repeated freeze/thaw cycles.
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 years
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun-Sat
Reported
1-4 days
Reference Interval
Effective August 17, 2015
Drugs Covered | Cutoff Concentrations |
Codeine | 20 ng/mL |
Morphine | 20 ng/mL |
6-acetylmorphine | 10 ng/mL |
Hydrocodone | 20 ng/mL |
Norhydrocodone | 20 ng/mL |
Hydromorphone | 20 ng/mL |
Oxycodone | 20 ng/mL |
Noroxycodone | 20 ng/mL |
Oxymorphone | 20 ng/mL |
Noroxymorphone | 20 ng/mL |
Interpretive Data
Methodology: Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Positive cutoff: 20 ng/mL except as specified below:
6-acetylmorphine10 ng/mL
For medical purposes only; not valid for forensic use.
Identification of specific drug(s) taken by specimen donor is problematic due to common metabolites, some of which are prescription drugs themselves. The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. All drug analytes covered are in the non-glucuronidated (free) forms. The concentration value must be greater than or equal to the cutoff to be reported as positive. A very small amount of an unexpected drug analyte in the presence of a large amount of an expected drug analyte may reflect pharmaceutical impurity. Interpretive questions should be directed to the laboratory.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
Note
Hotline History
CPT Codes
80361; 80365 (Alt code: G0480)
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
2005092 | Hydrocodone, Urn, Quant | 16252-9 |
2005098 | Oxycodone, Urn, Quant | 16249-5 |
2005099 | Oxymorphone, Urn, Quant | 17395-5 |
2005222 | Hydromorphone, Urn, Quant | 16998-7 |
2005223 | Codeine, Urn, Quant | 16250-3 |
2005224 | Morphine, Urn, Quant | 16251-1 |
2005225 | 6-acetylmorphine, Urn, Quant | 19593-3 |
2006968 | Noroxycodone, Urn, Quant | 61425-5 |
2006969 | Noroxymorphone, Urn, Quant | 90894-7 |
2008515 | Norhydrocodone, Urn, Quant | 61422-2 |
Aliases
- 6-Acetylmorphine
- 6-AM
- 6-MAM
- Anexsia
- Avinza
- Codeine
- Combunox
- Depalgos
- DepoDur
- Diacetylmorphine
- Diamorphine
- Dicodid
- Dihydromorphinone
- Dilaudid
- Dimorphone
- Drocode
- Duodin
- Duramorph
- Endocet
- Exalgo
- Heroin
- Histinex
- Hycet
- Hycodan
- Hycomine
- Hycotuss
- Hydrococet
- Hydrocodone
- Hydromet
- Hydromorphone
- Hydrovo
- Kadian
- Kolikodol
- Laudicon
- Loracet
- Lortab
- Mercodinone
- Methylmorphine
- Morphine
- MS Contin
- MS-Contin
- Norco
- Novahistex
- Numorphan
- Numorphone
- Opana
- Opium
- Oramorph
- Orthoxycol
- Oxycodone
- Oxymorphone
- Pain Management
- Pain Management, Opiates Expanded, Quantitative, with medMATCH, Urine
- Pain Management, Oxycodone, Quantitative, with medMATCH, Urine
- Palladone
- Paracodeine
- Paragoric
- Parzone
- Percocet
- Percodan
- Roxanol
- Roxicet
- Roxicodone
- Roxiprin
- Symtan
- Synkonin
- Targin
- Tussionex
- Tylox
- Vicodin
- Vicoprofen
- Zydone